Femasys (FEMY) Retained Earnings (2020 - 2026)
Femasys (FEMY) posted Retained Earnings of -$145.0 million for Q1 2026, down 199.0% on a QoQ basis from $146.4 million in Q4 2025, and down 8.93% year-over-year from -$159.2 million in Q1 2025.
Femasys (FEMY) Retained Earnings (2020 - 2026) Analysis & Trends
Femasys' Retained Earnings history runs 7 years deep, the most recent figure standing at -$145.0 million for Q1 2026.
- Quarterly Retained Earnings fell 8.93% year-over-year to -$145.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$145.0 million (down 8.93% YoY) and the FY2025 annual result came in at $146.4 million, up 215.13% from the prior year.
- Retained Earnings was -$145.0 million for Q1 2026 at Femasys, down from $146.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $146.4 million in Q4 2025 and bottomed at -$145.0 million in Q1 2026.
- A 5-year average of $14.3 million and a median of $108.7 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 235.27% — and 2025, when it tumbled 206.48%.
- Femasys' Retained Earnings stood at -$94.1 million in 2022, then soared by 231.71% to $124.0 million in 2023, then plunged by 202.59% to -$127.2 million in 2024, then jumped by 215.13% to $146.4 million in 2025, then sank by 199.0% to -$145.0 million in 2026.
- Business Quant data shows FEMY's Retained Earnings at -$145.0 million in Q1 2026, $146.4 million in Q4 2025, and $139.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 22.11 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1.76 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 122.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -24.91 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.98 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 1.81 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.55 Bn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | -144.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -144.98 Mn |
| Dec 31, 2025 | 146.45 Mn |
| Sep 30, 2025 | 139.72 Mn |
| Jun 30, 2025 | 137.39 Mn |
| Mar 31, 2025 | -133.10 Mn |
| Dec 31, 2024 | -127.20 Mn |
| Sep 30, 2024 | 125.47 Mn |
| Jun 30, 2024 | -116.67 Mn |
| Mar 31, 2024 | 124.99 Mn |
| Dec 31, 2023 | 123.99 Mn |
| Sep 30, 2023 | 112.88 Mn |
| Jun 30, 2023 | 110.98 Mn |
| Mar 31, 2023 | -97.08 Mn |
| Dec 31, 2022 | -94.13 Mn |
| Sep 30, 2022 | 108.73 Mn |
| Jun 30, 2022 | -88.26 Mn |
| Mar 31, 2022 | -85.62 Mn |
| Dec 31, 2021 | -82.74 Mn |
| Sep 30, 2021 | -80.38 Mn |
| Jun 30, 2021 | 108.34 Mn |